AISLING CAPITAL LLC
AISLING CAPITAL LLC is a Seed, Series A and Series C+ fund in the US and Western Europe writing $10M–$50M checks into Healthcare, biotechnology, medical-devices and pharma-tech.
- Stages
- Seed, Series A, Series C+
- Sectors
- Healthcare, biotechnology, medical-devices, pharma-tech
- Check size
- $10M–$50M
- Invests in
- US-wide, Western Europe
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2000
- Assets under management
- $1.8B
- Website
- aislingcapital.com
Thesis
Aisling Capital LLC is a venture capital and private equity firm founded in 2000, headquartered in New York City. The firm specializes in the healthcare and life sciences sectors, investing in companies developing innovative products, services, and technologies for unmet medical needs. With over $1.8 billion in committed capital, Aisling Capital targets companies from seed to growth equity stages, employing strategies including seed and venture financing, structured debt, royalty deals, and leveraged buyouts of profitable companies. They invest in both private and public companies, primarily in North America and Western Europe. Their typical deal size ranges from $10 million to $50 million, and they aim to partner with companies demonstrating strong scientific, regulatory, financial, and commercial potential, often engaging in non-control investments. The firm makes 2-6 deals annually and leads investments more frequently than average.
Common questions
Does AISLING CAPITAL LLC invest at the Seed stage?
Yes. AISLING CAPITAL LLC lists Seed, Series A and Series C+ among the stages it invests in.
What check size does AISLING CAPITAL LLC write?
AISLING CAPITAL LLC writes $10M–$50M checks.
Where does AISLING CAPITAL LLC invest?
AISLING CAPITAL LLC invests in the US and Western Europe.